BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21239999)

  • 21. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ; Uckun FM
    Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent synergistic anti-human immunodeficiency virus (HIV) effects using combinations of the CCR5 inhibitor aplaviroc with other anti-HIV drugs.
    Nakata H; Steinberg SM; Koh Y; Maeda K; Takaoka Y; Tamamura H; Fujii N; Mitsuya H
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2111-9. PubMed ID: 18378711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergy against drug-resistant HIV-1 with the microbicide antiretrovirals, dapivirine and tenofovir, in combination.
    Schader SM; Colby-Germinario SP; Schachter JR; Xu H; Wainberg MA
    AIDS; 2011 Aug; 25(13):1585-94. PubMed ID: 21633286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic Inhibition of R5 HIV-1 by the Fusion Protein (FLSC) IgG1 Fc and Maraviroc in Primary Cells: Implications for Prevention and Treatment.
    Latinovic OS; Zhang J; Tagaya Y; DeVico AL; Fouts TR; Schneider K; Lakowicz JR; Heredia A; Redfield RR
    Curr HIV Res; 2016; 14(1):24-36. PubMed ID: 26354735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel.
    Cranage M; Sharpe S; Herrera C; Cope A; Dennis M; Berry N; Ham C; Heeney J; Rezk N; Kashuba A; Anton P; McGowan I; Shattock R
    PLoS Med; 2008 Aug; 5(8):e157; discussion e157. PubMed ID: 18684007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced activity of carbosilane dendrimers against HIV when combined with reverse transcriptase inhibitor drugs: searching for more potent microbicides.
    Vacas-Córdoba E; Galán M; de la Mata FJ; Gómez R; Pion M; Muñoz-Fernández MÁ
    Int J Nanomedicine; 2014; 9():3591-600. PubMed ID: 25114528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explants.
    Herrera C; Cranage M; McGowan I; Anton P; Shattock RJ
    AIDS; 2011 Oct; 25(16):1971-9. PubMed ID: 21811139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitor.
    Fletcher P; Harman S; Azijn H; Armanasco N; Manlow P; Perumal D; de Bethune MP; Nuttall J; Romano J; Shattock R
    Antimicrob Agents Chemother; 2009 Feb; 53(2):487-95. PubMed ID: 19029331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triple combination of carbosilane dendrimers, tenofovir and maraviroc as potential microbicide to prevent HIV-1 sexual transmission.
    Sepúlveda-Crespo D; Sánchez-Rodríguez J; Serramía MJ; Gómez R; De La Mata FJ; Jiménez JL; Muñoz-Fernández MÁ
    Nanomedicine (Lond); 2015; 10(6):899-914. PubMed ID: 25867856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Candidate microbicide PPCM blocks human immunodeficiency virus type 1 infection in cell and tissue cultures and prevents genital herpes in a murine model.
    Mesquita PM; Wilson SS; Manlow P; Fischetti L; Keller MJ; Herold BC; Shattock RJ
    J Virol; 2008 Jul; 82(13):6576-84. PubMed ID: 18434407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro microbicidal activity of the nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781 against NNRTI-resistant human immunodeficiency virus type 1.
    Hossain MM; Parniak MA
    J Virol; 2006 May; 80(9):4440-6. PubMed ID: 16611904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaginal Microbicide Film Combinations of Two Reverse Transcriptase Inhibitors, EFdA and CSIC, for the Prevention of HIV-1 Sexual Transmission.
    Zhang W; Hu M; Shi Y; Gong T; Dezzutti CS; Moncla B; Sarafianos SG; Parniak MA; Rohan LC
    Pharm Res; 2015 Sep; 32(9):2960-72. PubMed ID: 25794967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of antiretroviral drugs as microbicides.
    Balzarini J; Schols D
    Curr HIV Res; 2012 Jan; 10(1):53-60. PubMed ID: 22264046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor.
    Liang T; Qiu J; Niu X; Ma Q; Zhou C; Chen P; Zhang Q; Chen M; Yang Z; Liu S; Li L
    Front Pharmacol; 2020; 11():603830. PubMed ID: 33519467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz.
    Kollmann C; Tremblay C; Giguel F; Chou TC; Hirsch MS
    Antivir Ther; 2001 Jun; 6(2):143-4. PubMed ID: 11491419
    [No Abstract]   [Full Text] [Related]  

  • 36. 3-Hydroxyphthalic Anhydride- Modified Rabbit Anti-PAP IgG as a Potential Bifunctional HIV-1 Entry Inhibitor.
    Zhang X; Chen J; Yu F; Wang C; Ren R; Wang Q; Tan S; Jiang S; Liu S; Li L
    Front Microbiol; 2018; 9():1330. PubMed ID: 29971062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 Infection.
    Minooei F; Fried JR; Fuqua JL; Palmer KE; Steinbach-Rankins JM
    Int J Nanomedicine; 2021; 16():1189-1206. PubMed ID: 33623382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased antiretroviral potency by the addition of enfuvirtide to a four-drug regimen in antiretroviral-naive, HIV-infected patients.
    Moltó J; Ruiz L; Valle M; Martinez-Picado J; Bonjoch A; Bravo I; Negredo E; Heilek-Sneider GM; Clotet B
    Antivir Ther; 2006; 11(1):47-51. PubMed ID: 16518959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal Applications.
    Gordts SC; Férir G; D'huys T; Petrova MI; Lebeer S; Snoeck R; Andrei G; Schols D
    PLoS One; 2015; 10(7):e0131219. PubMed ID: 26132818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic inhibition of HIV-1 infection by combinations of soluble polyanions with other potential microbicides.
    Gantlett KE; Weber JN; Sattentau QJ
    Antiviral Res; 2007 Sep; 75(3):188-97. PubMed ID: 17408760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.